| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52681-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47727-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08974 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-61908-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47908-0.1mg | |||
![Immunocytochemistry/Immunofluorescence: CREB [p Ser133] Antibody (M415) [NBP3-23244] - Immunocytochemical labeling of phosphorylated CREB in calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with mouse monoclonal CREB (Ser-133). The antibody was detected using goat anti-mouse DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23244_mouse-creb-p-ser133-mab-m415-19920231915415.jpg "Immunocytochemistry/Immunofluorescence: CREB [p Ser133] Antibody (M415) [NBP3-23244] - Immunocytochemical labeling of phosphorylated CREB in calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with mouse monoclonal CREB (Ser-133). The antibody was detected using goat anti-mouse DyLight(R) 594.")
![Western Blot: CREB [p Ser133] Antibody (M415) [NBP3-23244] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3 & 5) then the blots were treated with lambda phosphatase (lanes 2, 4 & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23244_mouse-creb-p-ser133-mab-m415-199202312523628.jpg)
![Western Blot: p38 alpha [p Tyr323] Antibody [NBP3-23249] - A) Western blot image of GST-recombinant p38 (K53M) mutant kinase untreated (lanes 1 & 3) or treated with Fyn kinase (lanes 2 & 4). B) Western blot analysis of p38 phosphorylation in mouse macrophages stimulated with 1 mM pervanadate for 30 min. (lanes 1 & 3) then the blot was treated with alkaline phosphatase (lanes 2 & 4). Both blots were probed with anti-p38 alpha (a.a. 319-328) (lanes 1 & 2) or anti-p38 alpha (Tyr-323) (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23249_rabbit-p38-alpha-p-tyr323-pab-19920231410135.jpg "Western Blot: p38 alpha [p Tyr323] Antibody [NBP3-23249] - A) Western blot image of GST-recombinant p38 (K53M) mutant kinase untreated (lanes 1 & 3) or treated with Fyn kinase (lanes 2 & 4). B) Western blot analysis of p38 phosphorylation in mouse macrophages stimulated with 1 mM pervanadate for 30 min. (lanes 1 & 3) then the blot was treated with alkaline phosphatase (lanes 2 & 4). Both blots were probed with anti-p38 alpha (a.a. 319-328) (lanes 1 & 2) or anti-p38 alpha (Tyr-323) (lanes 3 & 4).")
![Immunocytochemistry/Immunofluorescence: p38 alpha [p Tyr323] Antibody [NBP3-23249] - Immunocytochemical labeling of p38 MAPK in pervanadate-treated mouse C2C12. The cells were labeled with mouse monoclonal p38 alpha MAPK and rabbit polyclonal p38 MAPK (Tyr-323) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3.](http://images.novusbio.com/fullsize/nbp3-23249_rabbit-p38-alpha-p-tyr323-pab-19920231911472.jpg)
![Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Flow-Cytometry-NBP2-52681-img0001.jpg "Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: CREB Antibody [NBP3-23243] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3 & 5) then the blots were treated with lambda phosphatase (lanes 2, 4 & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23243_rabbit-creb-pab-19920231856929.jpg "Western Blot: CREB Antibody [NBP3-23243] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3 & 5) then the blots were treated with lambda phosphatase (lanes 2, 4 & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).")
![Immunocytochemistry/Immunofluorescence: CREB Antibody [NBP3-23243] - Immunocytochemical labeling of CREB in A431 that were fixed in paraformaldehyde and permeabilized using NP-40. The cells were labeled with rabbit polyclonal CREB (N-terminal region). The antibody was detected using goat anti-rabbit DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23243_rabbit-creb-pab-199202312523630.jpg)
![Immunocytochemistry/Immunofluorescence: CREB [p Ser271] Antibody [NBP3-23250] - Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23250_rabbit-creb-p-ser271-pab-1992023199286.jpg "Immunocytochemistry/Immunofluorescence: CREB [p Ser271] Antibody [NBP3-23250] - Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight(R) 594.")
![Western Blot: CREB [p Ser271] Antibody [NBP3-23250] - Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3, & 5) then blots were treated with lambda phosphatase (lanes 2, 4, & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23250_rabbit-creb-p-ser271-pab-189202317355213.jpg)
![Immunohistochemistry-Paraffin: Insulin Antibody (IRDN/805) - IHC-Prediluted [NBP2-48273] - Human pancreas stained with Insulin Monoclonal Antibody (IRDN/805).](http://images.novusbio.com/fullsize/Insulin-Antibody-IRDN-805-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48273-img0001.jpg "Immunohistochemistry-Paraffin: Insulin Antibody (IRDN/805) - IHC-Prediluted [NBP2-48273] - Human pancreas stained with Insulin Monoclonal Antibody (IRDN/805).")
![Immunocytochemistry/Immunofluorescence: CD47 Antibody (IAP/964) [NBP2-44408] - Immunofluorescence Analysis of PFA-fixed MCF-7 cells. CD47 Mouse Monoclonal Antibody (IAP/964) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Redot.](http://images.novusbio.com/fullsize/CD47-Antibody-IAP-964-Immunocytochemistry-Immunofluorescence-NBP2-44408-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD47 Antibody (IAP/964) [NBP2-44408] - Immunofluorescence Analysis of PFA-fixed MCF-7 cells. CD47 Mouse Monoclonal Antibody (IAP/964) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Redot.")
![Flow Cytometry: CD47 Antibody (IAP/964) [NBP2-44408] - Flow Cytometric Analysis of live-Jurkat cells. CD47 Mouse Monoclonal Antibody (IAP/964) followed by goat anti-mouse IgG-CF488 (blue); isotype control (red).](http://images.novusbio.com/fullsize/CD47-Antibody-IAP-964-Flow-Cytometry-NBP2-44408-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: CD47 Antibody (IAP/964) [NBP2-44408] - Immunofluorescence Analysis of Live Jurkat cells. CD47 Mouse Monoclonal Antibody (IAP/964) followed by goat anti-mouse IgG-CF488 (Green). The nuclear counterstain is Redot.](http://images.novusbio.com/fullsize/CD47-Antibody-IAP-964-Immunocytochemistry-Immunofluorescence-NBP2-44408-img0003.jpg)
![Western Blot: NAP1 Antibody [NBP1-26592] - Detection of Human and Mouse TAB3 by Western Blot. Samples: Whole cell lysate (50, 15 ug) from 293T and (50 ug) from HeLa and mouse NIH3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-TAB3 antibody NBP1-26592 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.](http://images.novusbio.com/fullsize/NAP1-Antibody-Western-Blot-NBP1-26592-img0003.jpg "<b>Biological Strategies Validation. </b>Western Blot: NAP1 Antibody [NBP1-26592] - Detection of Human and Mouse TAB3 by Western Blot. Samples: Whole cell lysate (50, 15 ug) from 293T and (50 ug) from HeLa and mouse NIH3T3 cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-TAB3 antibody NBP1-26592 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.")
![<b>Independent Antibodies Validation and Biological Strategies Validation.</b>Western Blot: NAP1 Antibody [NBP1-26592] - Whole cell lysate from HeLa, 293T and mouse NIH3T3 cells. TAB3 was also immunoprecipitated by rabbit anti-TAB3 antibody NBP1-26593.](http://images.novusbio.com/fullsize/NAP1-Antibody-Western-Blot-NBP1-26592-img0001.jpg)
![Immunoprecipitation: NAP1 Antibody [NBP1-26592] - Detection of human TAB3 by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HEK293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-TAB3 antibody NBP1-26592 (lot NBP1-26592-2) used for IP at 6 ug per reaction. TAB3 was also immunoprecipitated by a previous lot of this antibody (lot NBP1-26592-1). For blotting immunoprecipitated TAB3, NBP1-26592 was used at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 60 seconds.](http://images.novusbio.com/fullsize/NAP1-Antibody-Immunoprecipitation-NBP1-26592-img0004.jpg)
![Immunohistochemistry-Paraffin: GBP1 Antibody [NBP1-31560] - Paraffin-embedded SCC4 xenograft, using antibody at 1:100 dilution.](http://images.novusbio.com/fullsize/GBP1-Antibody-Immunohistochemistry-Paraffin-NBP1-31560-img0002.jpg "Immunohistochemistry-Paraffin: GBP1 Antibody [NBP1-31560] - Paraffin-embedded SCC4 xenograft, using antibody at 1:100 dilution.")
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (CVID3/155) [NBP2-44674] - Immunofluorescence staining of Raji cells. CD19 Antibody (CVID3/155) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red).](http://images.novusbio.com/fullsize/CD19-Antibody-CVID3-155-Immunocytochemistry-Immunofluorescence-NBP2-44674-img0003.jpg "Immunocytochemistry/Immunofluorescence: CD19 Antibody (CVID3/155) [NBP2-44674] - Immunofluorescence staining of Raji cells. CD19 Antibody (CVID3/155) followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Red Dot (Red).")
![Flow Cytometry: CD19 Antibody (CVID3/155) [NBP2-44674] - Flow cytometric analysis of lymphocyte-gated PBMCs. CD19 antibody (CVID3/155) labeled with CF568 (orange); unstained cells (gray).](http://images.novusbio.com/fullsize/CD19-Antibody-CVID3-155-Flow-Cytometry-NBP2-44674-img0004.jpg)
![Flow Cytometry: CD19 Antibody (CVID3/155) [NBP2-44674] - Flow Cytometric Analysis of Raji cells. CD19 Antibody (CVID3/155) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red).](http://images.novusbio.com/fullsize/CD19-Antibody-CVID3-155-Flow-Cytometry-NBP2-44674-img0002.jpg)
![Western Blot: Granzyme K Antibody (C3) [NBP3-41596] - Sample: Rat Lung lysate Primary Ab: 0.1ug/ml NBP3-41596; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41596_mouse-granzyme-k-mab-c3-612202421373025.jpg "Western Blot: Granzyme K Antibody (C3) [NBP3-41596] - Sample: Rat Lung lysate Primary Ab: 0.1ug/ml NBP3-41596; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunohistochemistry-Paraffin: Granzyme K Antibody (C3) [NBP3-41596] - DAB staining on IHC-P; Sample: Mouse Spleen Tissue; Primary Ab: 30ug/ml NBP3-41596; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41596_mouse-granzyme-k-mab-c3-61220242130430.jpg)
![Western Blot: Granzyme K Antibody (C3) [NBP3-41596] - Sample: Rat Lung lysate Primary Ab: 0.1ug/ml NBP3-41596; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41596_mouse-granzyme-k-mab-c3-612202421304359.jpg)